BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Prognosis
13 results:

  • 1. miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid leukemia by Inhibiting cdx2 Translation and Serve as Prognostic Biomarkers.
    Cheng YC; Fan Z; Liang C; Peng CJ; Li Y; Wang LN; Luo JS; Zhang XL; Liu Y; Zhang LD
    Technol Cancer Res Treat; 2024; 23():15330338241248576. PubMed ID: 38693824
    [No Abstract]    [Full Text] [Related]  

  • 2. The Dawn of next generation DNA sequencing in myelodysplastic syndromes- experience from Pakistan.
    Anwar N; Memon FA; Shahid S; Shakeel M; Irfan M; Arshad A; Naz A; Ujjan ID; Shamsi T
    BMC Genomics; 2021 Dec; 22(1):903. PubMed ID: 34915860
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular regulators of HOXA9 in acute myeloid leukemia.
    Aryal S; Zhang Y; Wren S; Li C; Lu R
    FEBS J; 2023 Jan; 290(2):321-339. PubMed ID: 34743404
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of cdx2 and IDH1/2 mutations.
    Yasuda T; Sanada M; Kawazu M; Kojima S; Tsuzuki S; Ueno H; Iwamoto E; Iijima-Yamashita Y; Yamada T; Kanamori T; Nishimura R; Kuwatsuka Y; Takada S; Tanaka M; Ota S; Dobashi N; Yamazaki E; Hirose A; Murayama T; Sumi M; Sato S; Tange N; Nakamura Y; Katsuoka Y; Sakaida E; Kawamata T; Iida H; Shiraishi Y; Nannya Y; Ogawa S; Taniwaki M; Asou N; Hatta Y; Kiyoi H; Matsumura I; Horibe K; Mano H; Naoe T; Miyazaki Y; Hayakawa F
    Blood; 2022 Mar; 139(12):1850-1862. PubMed ID: 34695176
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cdx2 expression in the hematopoietic lineage promotes leukemogenesis via TGFβ inhibition.
    Galland A; Gourain V; Habbas K; Güler Y; Martin E; Ebel C; Tavian M; Vallat L; Chenard MP; Mauvieux L; Freund JN; Duluc I; Domon-Dell C
    Mol Oncol; 2021 Sep; 15(9):2318-2329. PubMed ID: 33960108
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The clinical significance of cdx2 in leukemia: A new perspective for leukemia research.
    Darvishi M; Mashati P; Khosravi A
    Leuk Res; 2018 Sep; 72():45-51. PubMed ID: 30096576
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
    Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
    Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Expression and clinical significance of caudal type homeobox transcription factor-2 in adult acute lymphocytic leukemia].
    Lu HY; Xia HL; Chen XW; Zhu LX; Wang QY; Cheng X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):298-302. PubMed ID: 21518475
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL.
    Starkova J; Zamostna B; Mejstrikova E; Krejci R; Drabkin HA; Trka J
    Pediatr Blood Cancer; 2010 Dec; 55(6):1072-82. PubMed ID: 20672366
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Aberrant expression of the homeobox gene cdx2 in pediatric acute lymphoblastic leukemia.
    Riedt T; Ebinger M; Salih HR; Tomiuk J; Handgretinger R; Kanz L; Grünebach F; Lengerke C
    Blood; 2009 Apr; 113(17):4049-51. PubMed ID: 19218548
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The homeobox gene cdx2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia.
    Thoene S; Rawat VP; Heilmeier B; Hoster E; Metzeler KH; Herold T; Hiddemann W; Gökbuget N; Hoelzer D; Bohlander SK; Feuring-Buske M; Buske C
    Leukemia; 2009 Apr; 23(4):649-55. PubMed ID: 19158837
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.
    Mrózek K
    Semin Oncol; 2008 Aug; 35(4):365-77. PubMed ID: 18692687
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.
    Haas K; Kundi M; Sperr WR; Esterbauer H; Ludwig WD; Ratei R; Koller E; Gruener H; Sauerland C; Fonatsch C; Valent P; Wieser R
    Genes Chromosomes Cancer; 2008 Apr; 47(4):288-98. PubMed ID: 18181178
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.